The impact of baseline liver histology on virologic response to interferon-α2b+/-ρribavirin therapy in patients with chronic hepatitis C.

被引：0
|
作者：
Fang, JS
Goodman, ZD
Albrecht, JK
Yao, R
Garaud, JJ
Lau, JN
机构：
[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
[2] Armed Forces Inst Pathol, Washington, DC 20306 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
572
引用
收藏
页码：303A / 303A
页数：1
相关论文
共 50 条
  • [1] Interferon-β induction/interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
    Kim, KI
    Sasase, N
    Taniguchi, M
    Mita, K
    Kinoshita, K
    Togitani, T
    Shikata, M
    Kimura, N
    Izawa, S
    Ohtani, A
    Nakao, K
    Muramoto, Y
    Kim, SR
    Nabeshima, S
    Ishii, F
    Tanaka, K
    Hayashi, Y
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2005, 25 (02) : 71 - 76
  • [2] Impact of interferon alfa-2b and ribavirin on the liver fibrosis progression in patients with chronic hepatitis C.
    Poynard, T
    McHutchinson, J
    Davis, G
    Esteban-Mur, R
    Goodman, Z
    Bedossa, P
    Albrecht, J
    HEPATOLOGY, 1998, 28 (04) : 497A - 497A
  • [3] Combination Therapy with Interferon-α2b, Ribavirin, and Amantadine in Chronic Hepatitis C Nonresponders to Interferon and Ribavirin
    Paul J. Thuluvath
    Hemant Pande
    Joyce Maygers
    Digestive Diseases and Sciences, 2003, 48 : 594 - 597
  • [4] Combination therapy with interferon-α2b, ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin
    Thuluvath, PJ
    Pande, H
    Maygers, J
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (03) : 594 - 597
  • [5] The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C
    Myers, RP
    Thibault, V
    Poynard, T
    JOURNAL OF VIRAL HEPATITIS, 2003, 10 (02) : 103 - 110
  • [6] Impact of pegylated interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.
    Poynard, T
    McHutchison, J
    Manns, M
    Trepo, C
    Lindsay, K
    Goodman, Z
    Ling, MS
    Albrecht, JK
    HEPATOLOGY, 2001, 34 (04) : 244A - 244A
  • [7] Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C
    Horiike, N
    Onji, M
    JOURNAL OF GASTROENTEROLOGY, 2003, 38 (03) : 302 - 304
  • [8] Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C
    Norio Horiike
    Morikazu Onji
    Journal of Gastroenterology, 2003, 38 : 302 - 304
  • [9] IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
    Vijayaprakash Suppiah
    Max Moldovan
    Golo Ahlenstiel
    Thomas Berg
    Martin Weltman
    Maria Lorena Abate
    Margaret Bassendine
    Ulrich Spengler
    Gregory J Dore
    Elizabeth Powell
    Stephen Riordan
    David Sheridan
    Antonina Smedile
    Vincenzo Fragomeli
    Tobias Müller
    Melanie Bahlo
    Graeme J Stewart
    David R Booth
    Jacob George
    Nature Genetics, 2009, 41 : 1100 - 1104
  • [10] IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
    Suppiah, Vijayaprakash
    Moldovan, Max
    Ahlenstiel, Golo
    Berg, Thomas
    Weltman, Martin
    Abate, Maria Lorena
    Bassendine, Margaret
    Spengler, Ulrich
    Dore, Gregory J.
    Powell, Elizabeth
    Riordan, Stephen
    Sheridan, David
    Smedile, Antonina
    Fragomeli, Vincenzo
    Mueller, Tobias
    Bahlo, Melanie
    Stewart, Graeme J.
    Booth, David R.
    George, Jacob
    NATURE GENETICS, 2009, 41 (10) : 1100 - U74
12345